Skip to content
PepIndex

Evidence digest

What the research on IGF-1 LR3 actually shows

The indexed literature on IGF-1 LR3 includes human clinical or observational records (1 human-clinical or observational record). This digest describes the shape of that evidence and links the records behind it. It does not judge whether IGF-1 LR3 is safe or effective for any purpose, and nothing here is medical advice — the material sold by the vendors in this index is labeled for laboratory research use only.

Updated 25 Aug 2026 · 1 studies indexed · 1 human · compound record

Ranked vendors for IGF-1 LR3

Every vendor and price for IGF-1 LR3 →
  1. 1Amino Club$69.99/mg listed · 0 IGF-1 LR3 certificates86.8of 100Extensively documentedVisit Amino Club
  2. 2PeptidePlugs$70.00/mg listed · 1 IGF-1 LR3 certificate85.6of 100Extensively documentedVisit PeptidePlugs
  3. 3Hydro Research Peptides1 IGF-1 LR3 certificate83.9of 100Well documentedVisit Hydro Research Peptides

Ranked on this compound's price per mg against the market median, with testing and documentation counted as they are overall. What a vial contains is answered by that vendor's certificates, not by the studies below.

Studies indexed
1
Human evidence
1
Preclinical only
0

What is and is not established

What the literature supports

  • Human clinical or observational records are indexed for IGF-1 LR3 (1).
  • Published research is indexed back to 1993, with roughly 49 PubMed records located.
  • It is listed by one or more vendors tracked in this index.

What is NOT established

  • This index does not evaluate whether IGF-1 LR3 is safe or effective for any use.
  • Material sold by the vendors indexed here is labeled for laboratory research use only and is not a regulator-approved medicine in that form.
  • No dosing, protocol or human-use guidance is provided or implied anywhere in this index.

Studies indexed

1 human — controlled trial
Each row links to that study's permalink, where every digest citing it is listed. Findings are reported as the paper reported them — an animal result is not restated as a human one.
StudyEvidence typeModelnWhat it reportedSource
Differential effects of insulin-like growth factor-I and gonadotropins on the proliferative activity of two subgroups of granulosa cells: cumulus oophorus and mural granulosa cellsFertility and sterility · 2001Human — controlled trialNot recorded—To evaluate the physiological role of insulin-like growth factor-I (IGFI) and its interaction with gonadotropins in cell replication of two types of granulosa cells (cumulus oophorus, CC) and mural granulosa cells (MGC). Controlled randomized study of the action and interaction of gonadotropins and IGFI on granulosa cell replication in the rat. A university reproductive biology laboratory. The study examined the in vivo treatment with gonadotropins or an analogue of IGFI, lon…PMID 11334915

Vendors listing IGF-1 LR3

The evidence above describes the published literature. What any individual vial contains is a separate question, answered by that vendor’s certificate records rather than by any study on this page.

How to read this page

This digest describes what published research exists and what it does not establish. It is not a recommendation, contains no dosing information or protocols, and makes no claim that any compound is safe or effective for any purpose. Material listed by indexed vendors is labeled for laboratory research use only.